Last reviewed · How we verify
Cryopyrin associated periodic syndrome
Approved treatments
- Arcalyst · Regeneron
Arcalyst works by binding to Interleukin-1 beta, preventing its interaction with its receptor and reducing inflammation. - Anakinra · Biovitrum Ab
- Ilaris · Novartis Pharms
- Kineret · Biovitrum Ab
Kineret blocks the action of interleukin-1, a protein that promotes inflammation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cryopyrin associated periodic syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Cryopyrin associated periodic syndrome treatment landscape brief
- Cryopyrin associated periodic syndrome treatment updates RSS
Frequently asked questions about Cryopyrin associated periodic syndrome
What drugs treat Cryopyrin associated periodic syndrome?
Tracked treatments include Arcalyst, Anakinra, Ilaris, Kineret.
What is the treatment for Cryopyrin associated periodic syndrome?
Standard treatment for Cryopyrin associated periodic syndrome includes Arcalyst, Anakinra, Ilaris, Kineret. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Cryopyrin associated periodic syndrome patent cliff · Cryopyrin associated periodic syndrome CI report
- Treatment: Arcalyst · Regeneron
- Treatment: Anakinra · Biovitrum Ab
- Treatment: Ilaris · Novartis Pharms
- Treatment: Kineret · Biovitrum Ab
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing